Welcome to our dedicated page for Active Health news (Ticker: AHFD), a resource for investors and traders seeking the latest updates and insights on Active Health stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Active Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Active Health's position in the market.
Active Health Foods, Inc. (OTC: AHFD) has rescinded its Share Purchase Agreement with Bioidentical Hormones, Inc. due to inability to secure regulatory approval for a vital reverse-split of shares. The agreement termination follows FINRA's notice that Active has not met its SEC filing obligations since 2015. President Joe Wallace indicated that the issue stemmed from prior management and deemed it 'insurmountable.' The company is now exploring negotiations with another healthcare entity to replace BIO.
Active Health Foods, Inc. (AHFD) has terminated its $20 million Regulation A public offering and approved a substantial 1-for-7,000 reverse stock split. Following the split, the company's total shares will be reduced to 100 million, down from 37 billion authorized previously. This move aims to qualify for NASDAQ Capital Market listing, expected in Q1 2023. President Joe Wallace stated that the goal is to uplist once the stock trades at $4.00 per share for 90 days, enhancing shareholder value and attracting new market makers.
Active Health Foods, Inc. (OTC: AHFD) has appointed Dr. Philip Lee Miller and Dr. Aubrey Oliver to the Board of Directors of its subsidiary, Bioidentical Hormones, Inc. Dr. Miller, a seasoned leader in Anti-Aging medicine with over 45 years of experience, has been pivotal in the field since 1996. Dr. Oliver, based in Jamaica, specializes in Functional Medicine and Bioenergetics therapy, advocating for preventive and regenerative health. Joe Wallace, AHFD President, highlighted the extensive experience of the BIO Board, which has trained numerous Anti-Aging physicians worldwide.
Active Health Foods, Inc. (OTC: AHFD) announces the appointment of Dr. Philip Lee Miller and Dr. Aubrey Oliver to the Board of Directors of its subsidiary, Bioidentical Hormones, Inc. Dr. Miller, a leader in anti-aging integrative medicine, has over 45 years of experience and is recognized for his contributions to the field. Dr. Oliver, a Functional Medicine Physician from Jamaica, focuses on preventive and alternative health approaches. President Joe Wallace highlighted that these additions bring over 35 years of combined expertise in Bioidentical Hormone Replacement Therapy, enhancing the company’s leadership.
Active Health Foods, Inc. (OTC: AHFD) appoints Dr. Jonathan Wright, Holly Han, and Michael Cohen to the Board of Directors of its subsidiary Bioidentical Hormones, Inc. Dr. Wright is a pioneer in bio-identical hormone replacement therapy, bringing over 50,000 research papers worth of experience. His wife, Holly Han, has 35 years of experience in hormone replacement therapy and clinic operations. Michael Cohen, an attorney specializing in healthcare law, adds his expertise in healthcare transactions and regulatory law. The company recently acquired Bioidentical Hormones, Inc. and focuses on healthcare and anti-aging.
Active Health Foods, Inc. (OTC: AHFD) has appointed Dr. Michael Galitzer and Dr. Ron Rothenberg to its subsidiary Bioidentical Hormones, Inc. (BIO) Board of Directors. Dr. Galitzer, a leader in anti-aging medicine, brings extensive experience with high-profile clients seeking advanced health solutions. Dr. Rothenberg, recognized for his work in Preventive and Regenerative Medicine, has educated over 25,000 physicians. AHFD is committed to enhancing its board with notable members and has recently acquired Bioidentical Hormones, Inc. and its subsidiary, Australian Menopause Centre.
Active Health Foods, Inc. (OTC: AHFD) announces Dr. Gary Aaron's appointment as CEO and Board member, effective immediately. Dr. Aaron brings 20 years of experience running the Australian Menopause Centre. He will oversee operations for Bioidentical Hormones Inc. Dr. Thierry Hertoghe has joined as Chairman of the Scientific Board, enhancing leadership with significant expertise in anti-aging medicine.
Both leaders hold a combined 22% stake in AHFD, strengthening alignment with shareholders. The company plans to announce additional board members soon.
Cannabis Global, Inc. (OTC PINK:CBGL) and Active Health Foods, Inc. (OTC PINK:AHFD) announced a proposed joint venture with The Hub Craft, a Massachusetts cannabis company. This venture aims to introduce notable brands like Freeway Cannabis by Rick Ross, Payton's Place by Gary Payton, and TRUTH34 by Paul Pierce into the California market. The venture would grant exclusive rights to Hub Craft products in California and an option to acquire a 51% stake for $15 million. While terms have been agreed upon, a definitive agreement has yet to be signed.
Cannabis Global, Inc. (OTC PINK:CBGL) announced a non-binding letter of intent to form a joint venture with The Hub Craft and Active Health Foods (OTC PINK:AHFD) to enter California's cannabis market. The deal includes an option to acquire a 51% stake in Hub Craft for $15 million within nine months. Massachusetts' cultivation licenses and market dynamics are viewed favorably compared to overproduced markets like California. No definitive agreement has been reached yet, and further details must be finalized before proceeding.
Active Health Foods, Inc. (OTC: AHFD), operating under the brand CoinChamp, has launched a $15 million Regulation A+ funding campaign to develop a universal function NFT platform. This platform aims to democratize access to the NFT marketplace, allowing users to participate without prior expertise. The company has engaged MEV, LLC for development and plans to optimize its existing CoinChamp prediction platform. The offering price is set at $0.0015 per share, facilitating rapid development of essential software assets.
FAQ
What is the current stock price of Active Health (AHFD)?
What is the market cap of Active Health (AHFD)?
